As of September 30, 2007 the company had 3,541 employees compared to 3,260 employees on June 30, 2007.
Business Outlook for Full Year 2007
The company maintains its full-year 2007 net revenue guidance range of RMB2,155 million to RMB2,185 million, representing annual growth of 42% to 44% over full fiscal year 2006.
The company also maintains its full-year 2007 non-GAAP net income guidance range of RMB600 million to RMB630 million, representing annual growth of 44% to 51% over full fiscal year 2006.
Non-GAAP net income per share is expected to be in the range of RMB5.31 to RMB5.58 on a fully diluted basis, assuming an estimated diluted share count of 113 million.
The company estimates its total share-based compensation expenses in 2007 will be approximately RMB60 million to RMB64 million based on the employee share options that have been granted as of November 1, 2007. This estimate is subject to the finalization of the option pricing model used to estimate the fair value of the options recently granted. Total expense and/or amortization of intangible assets related to the April 2006 acquisition of minority interest will be approximately RMB18.8 million in 2007.
The company expects its updated capital expenditure for 2007 to be in the range of RMB350 million to RMB400 million from the previous range of RMB400 million to RMB480 million.
The company's practice is to provide guidance on a full year basis only. This forecast reflects Mindray's current and preliminary views, which are subject to change.
Mr. Xu Hang, Mindray's chairman and co-chief executive officer and Mr.
Li Xiting, Mindray's president and co-chief executive officer, have both
recently entered into "10b5-1" selling plans to sell a portion of their
|SOURCE Mindray Medical International Limited|
Copyright©2007 PR Newswire.
All rights reserved